共 194 条
[1]
De Rechter S(2017)Is autosomal dominant polycystic kidney disease becoming a pediatric disorder? Front Pediatr 5 272-726
[2]
Breysem L(2019)International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people Nat Rev Nephrol 15 713-2443
[3]
Mekahli D(2011)Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease Clin J Am Soc Nephrol 6 2439-1660
[4]
Gimpel C(1994)The spectrum of autosomal dominant polycystic kidney disease in children J Am Soc Nephrol 4 1654-1129
[5]
Bergmann C(2012)Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation Kidney Int 82 1121-1147
[6]
Bockenhauer D(2016)Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis Arch Dis Child 101 1142-537
[7]
Helal I(2015)Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians Clin Kidney J 8 531-1021
[8]
Reed B(2019)Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial Eur J Pediatr 178 1013-46
[9]
McFann K(2023)Tolvaptan for children and adolescents with autosomal dominant polycystic kidney disease: randomized controlled trial Clin J Am Soc Nephrol 18 36-487
[10]
Yan XD(2022)The wind of change in the management of autosomal dominant polycystic kidney disease in childhood Pediatr Nephrol 37 473-951